BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 25510279)

  • 21. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
    Phillips A; Blaydes JP
    Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The eukaryotic translation initiation factor eIF4E unexpectedly acts in splicing thereby coupling mRNA processing with translation: eIF4E induces widescale splicing reprogramming providing system-wide connectivity between splicing, nuclear mRNA export and translation.
    Borden KLB
    Bioessays; 2024 Jan; 46(1):e2300145. PubMed ID: 37926700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. hnRNP K binds a core polypyrimidine element in the eukaryotic translation initiation factor 4E (eIF4E) promoter, and its regulation of eIF4E contributes to neoplastic transformation.
    Lynch M; Chen L; Ravitz MJ; Mehtani S; Korenblat K; Pazin MJ; Schmidt EV
    Mol Cell Biol; 2005 Aug; 25(15):6436-53. PubMed ID: 16024782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia.
    Urtishak KA; Wang LS; Culjkovic-Kraljacic B; Davenport JW; Porazzi P; Vincent TL; Teachey DT; Tasian SK; Moore JS; Seif AE; Jin S; Barrett JS; Robinson BW; Chen IL; Harvey RC; Carroll MP; Carroll AJ; Heerema NA; Devidas M; Dreyer ZE; Hilden JM; Hunger SP; Willman CL; Borden KLB; Felix CA
    Oncogene; 2019 Mar; 38(13):2241-2262. PubMed ID: 30478448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities.
    Topisirovic I; Ruiz-Gutierrez M; Borden KL
    Cancer Res; 2004 Dec; 64(23):8639-42. PubMed ID: 15574771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
    Topisirovic I; Guzman ML; McConnell MJ; Licht JD; Culjkovic B; Neering SJ; Jordan CT; Borden KL
    Mol Cell Biol; 2003 Dec; 23(24):8992-9002. PubMed ID: 14645512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting eIF4E signaling with ribavirin as a sensitizing strategy for ovarian cancer.
    Jin J; Xiang W; Wu S; Wang M; Xiao M; Deng A
    Biochem Biophys Res Commun; 2019 Mar; 510(4):580-586. PubMed ID: 30739792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribavirin treatment effects on breast cancers overexpressing eIF4E, a biomarker with prognostic specificity for luminal B-type breast cancer.
    Pettersson F; Yau C; Dobocan MC; Culjkovic-Kraljacic B; Retrouvey H; Puckett R; Flores LM; Krop IE; Rousseau C; Cocolakis E; Borden KL; Benz CC; Miller WH
    Clin Cancer Res; 2011 May; 17(9):2874-84. PubMed ID: 21415224
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.
    Topisirovic I; Culjkovic B; Cohen N; Perez JM; Skrabanek L; Borden KL
    EMBO J; 2003 Feb; 22(3):689-703. PubMed ID: 12554669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of heat shock protein 27 on extravillous trophoblast differentiation and on eukaryotic translation initiation factor 4E expression.
    Sadeh-Mestechkin D; Epstein Shochet G; Pomeranz M; Fishman A; Drucker L; Biron-Shental T; Lishner M; Tartakover Matalon S
    Mol Hum Reprod; 2014 May; 20(5):422-32. PubMed ID: 24431103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5' cap-binding protein, eIF4E.
    Dostie J; Ferraiuolo M; Pause A; Adam SA; Sonenberg N
    EMBO J; 2000 Jun; 19(12):3142-56. PubMed ID: 10856257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabine.
    Assouline S; Gasiorek J; Bergeron J; Lambert C; Culjkovic-Kraljacic B; Cocolakis E; Zakaria C; Szlachtycz D; Yee K; Borden KLB
    Haematologica; 2023 Nov; 108(11):2946-2958. PubMed ID: 36951168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of eIF4E cooperates with chemotherapy and immunotherapy in renal cell carcinoma.
    Cao J; Sun X; Zhang X; Chen D
    Clin Transl Oncol; 2018 Jun; 20(6):761-767. PubMed ID: 29086249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E.
    Culjkovic B; Topisirovic I; Borden KL
    Cell Cycle; 2007 Jan; 6(1):65-9. PubMed ID: 17245113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
    Cohen N; Sharma M; Kentsis A; Perez JM; Strudwick S; Borden KL
    EMBO J; 2001 Aug; 20(16):4547-59. PubMed ID: 11500381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.
    Kentsis A; Topisirovic I; Culjkovic B; Shao L; Borden KL
    Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18105-10. PubMed ID: 15601771
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oncogene eIF4E: using biochemical insights to target cancer.
    Carroll M; Borden KL
    J Interferon Cytokine Res; 2013 May; 33(5):227-38. PubMed ID: 23472659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear eIF4E Stimulates 3'-End Cleavage of Target RNAs.
    Davis MR; Delaleau M; Borden KLB
    Cell Rep; 2019 Apr; 27(5):1397-1408.e4. PubMed ID: 31042468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia.
    Hariri F; Arguello M; Volpon L; Culjkovic-Kraljacic B; Nielsen TH; Hiscott J; Mann KK; Borden KL
    Leukemia; 2013 Oct; 27(10):2047-55. PubMed ID: 23467026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A blood pact: the significance and implications of eIF4E on lymphocytic leukemia.
    Venturi V; Masek T; Pospisek M
    Physiol Res; 2018 Jul; 67(3):363-382. PubMed ID: 29527921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.